| Peter Wagner, MD | |
|
350 Heritage Way, Suite 1100, Kalispell, MT 59901-3158 | |
| (406) 752-8900 | |
| (406) 752-8909 |
| Full Name | Peter Wagner |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 32 Years |
| Location | 350 Heritage Way, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245440841 | NPI | - | NPPES |
| 04208790 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | PENDING (Colorado) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 12637 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| Cabinet Peaks Medical Center | Libby, MT | Hospital |
| North Valley Hospital | Whitefish, MT | Hospital |
| St Luke Community Hospital | Ronan, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Agilent Technologies Inc. and the University of Technology, Sydney, today announced the establishment of a joint nuclear magnetic resonance research facility.
Three recent reports - a one-year assessment released by the Partnership for Maternal, Newborn and Child Health of the WHO on Tuesday, an analysis by the Institute for Health Metrics and Evaluation at the University of Washington published on Tuesday in the Lancet, and a Save the Children report released on Monday entitled "No Child out of Reach" - examine the progress of the global campaign to save mothers and children under five in developing nations and evaluate whether Millennium Development Goals 4 and 5, reducing child mortality by two-thirds between 1990 and 2015 and maternal deaths by three-quarters over the same period, can be met.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Standing for long periods during pregnancy may curb the growth of the developing fetus, suggests research published online in Occupational and Environmental Medicine.
When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
› Verified 8 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Agilent Technologies Inc. and the University of Technology, Sydney, today announced the establishment of a joint nuclear magnetic resonance research facility.
Three recent reports - a one-year assessment released by the Partnership for Maternal, Newborn and Child Health of the WHO on Tuesday, an analysis by the Institute for Health Metrics and Evaluation at the University of Washington published on Tuesday in the Lancet, and a Save the Children report released on Monday entitled "No Child out of Reach" - examine the progress of the global campaign to save mothers and children under five in developing nations and evaluate whether Millennium Development Goals 4 and 5, reducing child mortality by two-thirds between 1990 and 2015 and maternal deaths by three-quarters over the same period, can be met.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Standing for long periods during pregnancy may curb the growth of the developing fetus, suggests research published online in Occupational and Environmental Medicine.
When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Wagner, MD 350 Heritage Way, Suite 1100, Kalispell, MT 59901-3158 Ph: (406) 752-8900 | Peter Wagner, MD 350 Heritage Way, Suite 1100, Kalispell, MT 59901-3158 Ph: (406) 752-8900 |
News Archive
Agilent Technologies Inc. and the University of Technology, Sydney, today announced the establishment of a joint nuclear magnetic resonance research facility.
Three recent reports - a one-year assessment released by the Partnership for Maternal, Newborn and Child Health of the WHO on Tuesday, an analysis by the Institute for Health Metrics and Evaluation at the University of Washington published on Tuesday in the Lancet, and a Save the Children report released on Monday entitled "No Child out of Reach" - examine the progress of the global campaign to save mothers and children under five in developing nations and evaluate whether Millennium Development Goals 4 and 5, reducing child mortality by two-thirds between 1990 and 2015 and maternal deaths by three-quarters over the same period, can be met.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Standing for long periods during pregnancy may curb the growth of the developing fetus, suggests research published online in Occupational and Environmental Medicine.
When the heart is stopped and restarted, the patient's life may be saved but their brain is often permanently damaged. Therapeutic hypothermia, a treatment in which the patient's body temperature is lowered and maintained several degrees below normal for a period of time, has been shown to mitigate these harmful effects and improve survival in adults.
› Verified 8 days ago
Dr. Tobin James Hoppes, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 75 Claremont St Ste H, Kalispell, MT 59901 Phone: 406-752-7406 Fax: 406-752-7544 | |
Marise K Johnson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1280 Burns Way, Kalispell, MT 59901 Phone: 406-755-5266 Fax: 406-755-0228 | |
Kerry J Eby, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-6725 | |
Dr. Jeffrey W. Watkins, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 350 Heritage Way Ste 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-275-8996 | |
Torbjorn Ingvar Joreteg, MD PHD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 160 Heritage Way, Kalispell, MT 59901 Phone: 406-755-7785 Fax: 406-755-7857 | |
Nathaniel Lyle Hall, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2100, Kalispell, MT 59901 Phone: 406-257-8992 Fax: 406-751-4161 | |
Anna Rose Robbins, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 310 Sunnyview Ln, Northwest Hospitalists, Kalispell, MT 59901 Phone: 406-751-5310 Fax: 406-751-5769 |